Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

Rosalind J Carter, Reynold G B Senesi, Peter Dawson, Ibrahim Gassama, S A S Kargbo, Carey R Petrie, Mohamed Hashim Rogers, Mohamed Samai, Elizabeth T Luman, Rosalind J Carter, Reynold G B Senesi, Peter Dawson, Ibrahim Gassama, S A S Kargbo, Carey R Petrie, Mohamed Hashim Rogers, Mohamed Samai, Elizabeth T Luman

Abstract

ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Figures

Figure 1.
Figure 1.
Postenrollment and postvaccination follow-up of the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) participants.
Figure 2.
Figure 2.
Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) participant retention and compliance CONSORT diagram. aIncluded in the vaccinated group; not eligible for crossover vaccination.

Source: PubMed

Подписаться